The UK’s GW Pharma has insisted there will be no repeat of the controversy seen with cystic fibrosis drugs after NICE said “no” to regular NHS funding for its Epidyolex for rare forms of ch
Health secretary Matt Hancock responded to an urgent question tabled by Conservative MP Sir Mike Penning yesterday, following the seizure of £4,000-worth of medical cannabis products at Sou
Belgium’s UCB has joined forces with the UK’s Epilepsy Society in a collaboration aimed at finding treatments for people who have the disease, but do not respond to current treatments.